SI2242769T1 - Protitelesa anti-kadherin-11 EC domene za zdravljenje vnetnih obolenj sklepov - Google Patents
Protitelesa anti-kadherin-11 EC domene za zdravljenje vnetnih obolenj sklepovInfo
- Publication number
- SI2242769T1 SI2242769T1 SI200931574T SI200931574T SI2242769T1 SI 2242769 T1 SI2242769 T1 SI 2242769T1 SI 200931574 T SI200931574 T SI 200931574T SI 200931574 T SI200931574 T SI 200931574T SI 2242769 T1 SI2242769 T1 SI 2242769T1
- Authority
- SI
- Slovenia
- Prior art keywords
- cadherin
- domain antibodies
- treating inflammatory
- inflammatory joint
- joint disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/515—Complete light chain, i.e. VL + CL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/74—Inducing cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1073408P | 2008-01-11 | 2008-01-11 | |
| EP09700394.1A EP2242769B1 (en) | 2008-01-11 | 2009-01-09 | Anti-cadherin-11 ec1 domain antibodies for treating inflammatory joint disorders |
| PCT/US2009/000162 WO2009089062A2 (en) | 2008-01-11 | 2009-01-09 | Cadherin-11 ecl domain antagonists for treating inflammatory joint disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2242769T1 true SI2242769T1 (sl) | 2017-02-28 |
Family
ID=40602259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200931574T SI2242769T1 (sl) | 2008-01-11 | 2009-01-09 | Protitelesa anti-kadherin-11 EC domene za zdravljenje vnetnih obolenj sklepov |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US8591888B2 (sl) |
| EP (2) | EP3181588A1 (sl) |
| JP (1) | JP5511684B2 (sl) |
| CN (1) | CN101952316B (sl) |
| AU (1) | AU2009204467B2 (sl) |
| BR (1) | BRPI0906492A2 (sl) |
| CA (1) | CA2711394A1 (sl) |
| DK (1) | DK2242769T3 (sl) |
| ES (1) | ES2611102T3 (sl) |
| HU (1) | HUE031207T2 (sl) |
| IL (1) | IL206880A (sl) |
| MX (1) | MX2010007551A (sl) |
| PL (1) | PL2242769T3 (sl) |
| SI (1) | SI2242769T1 (sl) |
| WO (1) | WO2009089062A2 (sl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3181588A1 (en) | 2008-01-11 | 2017-06-21 | Adheron Therapeutics, Inc. | Cadherin-11 antagonists and methods for the treatment of inflammatory joint disorders |
| US8877188B2 (en) | 2010-05-04 | 2014-11-04 | The Brigham And Women's Hospital, Inc. | Detection and treatment of non-dermal fibrosis |
| JP5911848B2 (ja) * | 2010-05-04 | 2016-04-27 | ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド | 線維症の検出および処置 |
| BR112013001062A2 (pt) * | 2010-07-15 | 2016-05-24 | Synovex Corp | anticorpos humanizados que visam o domínio ec1 de caderina-11 e composições e métodos relacionados |
| WO2013130767A1 (en) | 2012-02-29 | 2013-09-06 | Pulmatrix, Inc. | Inhalable dry powders |
| KR20130142025A (ko) * | 2012-06-18 | 2013-12-27 | 한국생명공학연구원 | 카드헤린―１１ 단백질의 발현 또는 활성 억제제를 포함하는 대장암 치료 또는 전이 억제용 약학적 조성물 |
| US11097005B2 (en) | 2014-12-15 | 2021-08-24 | The Brigham And Women's Hospital, Inc. | Use of cadherin-11 antagonists to treat metabolic disorders and/or increase insulin sensitivity |
| WO2016196146A1 (en) | 2015-05-29 | 2016-12-08 | Children's Hospital Medical Center | Cdh26 based therapeutic agents and their use |
| KR101654526B1 (ko) * | 2015-10-19 | 2016-09-06 | 한국생명공학연구원 | 카드헤린―１１ 단백질의 발현 또는 활성 억제제를 포함하는 대장암 치료 또는 전이 억제용 약학적 조성물 |
| EP4059570A1 (en) | 2016-01-13 | 2022-09-21 | Children's Hospital Medical Center | Compositions and methods for treating allergic inflammatory conditions |
| US11859250B1 (en) | 2018-02-23 | 2024-01-02 | Children's Hospital Medical Center | Methods for treating eosinophilic esophagitis |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US248220A (en) * | 1881-10-11 | Machine for graining and dicing leather | ||
| US229811A (en) * | 1880-07-13 | dtjnlop | ||
| US253200A (en) * | 1882-02-07 | Timothy guilford | ||
| US110755A (en) * | 1871-01-03 | Improvement in spike-machines | ||
| US248219A (en) * | 1881-10-11 | Panorama-toy | ||
| US215482A (en) * | 1879-05-20 | Improvement in spring be d-bottoms | ||
| US8323A (en) * | 1851-08-26 | colne | ||
| US96746A (en) * | 1869-11-09 | Improvement in mechanical movements | ||
| US229199A (en) * | 1880-06-22 | Wood-working machine | ||
| US4172124A (en) | 1978-04-28 | 1979-10-23 | The Wistar Institute | Method of producing tumor antibodies |
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| EP0232262A4 (en) | 1985-08-15 | 1989-09-19 | Stauffer Chemical Co | MICROORGANISM PRODUCING TRYPTOPHANE. |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| DK0533838T3 (da) | 1990-06-11 | 1998-02-23 | Nexstar Pharmaceuticals Inc | Nukleinsyreligander |
| US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
| DE59109032D1 (de) | 1990-06-28 | 1998-09-03 | Hoechst Ag | Fusionsproteine mit immunglobulinanteilen, ihre Herstellung und Verwendung |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5770429A (en) | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5440021A (en) | 1991-03-29 | 1995-08-08 | Chuntharapai; Anan | Antibodies to human IL-8 type B receptor |
| DE69233482T2 (de) | 1991-05-17 | 2006-01-12 | Merck & Co., Inc. | Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen |
| WO1993006213A1 (en) | 1991-09-23 | 1993-04-01 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
| DE614989T1 (de) | 1993-02-17 | 1995-09-28 | Morphosys Proteinoptimierung | Verfahren für in vivo Selektion von Ligandenbindende Proteine. |
| CU22584A1 (es) | 1995-11-17 | 1999-11-03 | Centro Inmunologia Molecular | Composiciones farmacéuticas que contienen un anticuerpo monoclonal que reconoce el antígeno de diferenciación leucocitario humano cd6 y sus usos para el diagnóstico y tratamiento de la psoriasis |
| US5859136A (en) * | 1997-11-03 | 1999-01-12 | E. I. Du Pont De Nemours And Company | Coating composition containing an amine functional dispersed polymer and an isocyanate curing agent |
| US6638911B1 (en) | 1998-05-05 | 2003-10-28 | Adherex Technologies Inc. | Compounds and methods for modulating desmosomal cadherin-mediated functions |
| US7481999B2 (en) | 1998-05-05 | 2009-01-27 | Adherex Technologies, Inc. | Compounds and methods for modulating OB-cadherin-mediated function |
| CA2327530A1 (en) | 1998-05-05 | 1999-11-11 | Adherex Technologies, Inc. | Compounds and methods for modulating nonclassical cadherin-mediated functions |
| US6472367B1 (en) | 1998-05-05 | 2002-10-29 | Adherex Technologies, Inc. | Compounds and methods for modulating OB-cadherin mediated cell adhesion |
| US6680175B2 (en) | 1998-05-05 | 2004-01-20 | Adherex Technologies, Inc. | Methods for diagnosing and evaluating cancer |
| EP1207905B1 (en) | 1999-09-03 | 2010-09-01 | The Brigham And Women's Hospital, Inc. | Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| US6787136B1 (en) * | 1999-09-03 | 2004-09-07 | The Brigham And Women's Hospital, Inc. | Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| US20040110755A1 (en) * | 2002-08-13 | 2004-06-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Combination therapy with p38 MAP kinase inhibitors and their pharmaceutical compositions |
| AU2003298475A1 (en) * | 2002-11-14 | 2004-06-18 | Adherex Technologies, Inc. | Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion |
| US6952969B2 (en) * | 2003-09-30 | 2005-10-11 | The Aerospace Corporation | Ceramic ball bearing fracture test method |
| EP1853255A4 (en) * | 2005-02-22 | 2009-07-08 | Gemin X Pharmaceuticals Canada | METHODS FOR TREATING ARTHRITIS USING TRIHETEROCYCLIC COMPOUNDS |
| EP3181588A1 (en) | 2008-01-11 | 2017-06-21 | Adheron Therapeutics, Inc. | Cadherin-11 antagonists and methods for the treatment of inflammatory joint disorders |
| WO2009101059A2 (en) | 2008-02-11 | 2009-08-20 | Novartis Ag | Methods of using cadherin 11 (cdh11) antagonists |
| CA2760642A1 (en) * | 2009-05-01 | 2010-11-04 | The University Of Tokyo | Anti-cadherin antibody |
| BR112013001062A2 (pt) | 2010-07-15 | 2016-05-24 | Synovex Corp | anticorpos humanizados que visam o domínio ec1 de caderina-11 e composições e métodos relacionados |
-
2009
- 2009-01-09 EP EP16194905.2A patent/EP3181588A1/en not_active Withdrawn
- 2009-01-09 ES ES09700394.1T patent/ES2611102T3/es active Active
- 2009-01-09 JP JP2010542284A patent/JP5511684B2/ja active Active
- 2009-01-09 EP EP09700394.1A patent/EP2242769B1/en active Active
- 2009-01-09 CN CN200980101955.3A patent/CN101952316B/zh active Active
- 2009-01-09 US US12/811,921 patent/US8591888B2/en active Active
- 2009-01-09 MX MX2010007551A patent/MX2010007551A/es active IP Right Grant
- 2009-01-09 PL PL09700394T patent/PL2242769T3/pl unknown
- 2009-01-09 HU HUE09700394A patent/HUE031207T2/hu unknown
- 2009-01-09 CA CA2711394A patent/CA2711394A1/en not_active Abandoned
- 2009-01-09 AU AU2009204467A patent/AU2009204467B2/en not_active Ceased
- 2009-01-09 SI SI200931574T patent/SI2242769T1/sl unknown
- 2009-01-09 DK DK09700394.1T patent/DK2242769T3/en active
- 2009-01-09 WO PCT/US2009/000162 patent/WO2009089062A2/en active Application Filing
- 2009-01-09 BR BRPI0906492A patent/BRPI0906492A2/pt not_active IP Right Cessation
- 2009-04-22 US US12/427,993 patent/US7972846B2/en active Active
-
2010
- 2010-07-08 IL IL206880A patent/IL206880A/en not_active IP Right Cessation
- 2010-07-15 US US12/837,110 patent/US20110045003A1/en not_active Abandoned
-
2013
- 2013-11-01 US US14/070,106 patent/US9315568B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HUE031207T2 (hu) | 2017-07-28 |
| EP2242769B1 (en) | 2016-11-02 |
| AU2009204467A1 (en) | 2009-07-16 |
| AU2009204467B2 (en) | 2012-09-06 |
| US8591888B2 (en) | 2013-11-26 |
| US20090253200A1 (en) | 2009-10-08 |
| DK2242769T3 (en) | 2017-02-06 |
| JP5511684B2 (ja) | 2014-06-04 |
| CN101952316B (zh) | 2015-04-01 |
| CN101952316A (zh) | 2011-01-19 |
| IL206880A (en) | 2014-12-31 |
| PL2242769T3 (pl) | 2017-06-30 |
| US7972846B2 (en) | 2011-07-05 |
| WO2009089062A3 (en) | 2009-09-24 |
| WO2009089062A2 (en) | 2009-07-16 |
| ES2611102T3 (es) | 2017-05-04 |
| US20110045003A1 (en) | 2011-02-24 |
| US9315568B2 (en) | 2016-04-19 |
| EP3181588A1 (en) | 2017-06-21 |
| EP2242769A2 (en) | 2010-10-27 |
| US20140120104A1 (en) | 2014-05-01 |
| WO2009089062A8 (en) | 2010-09-02 |
| IL206880A0 (en) | 2010-12-30 |
| US20110008323A1 (en) | 2011-01-13 |
| CA2711394A1 (en) | 2009-07-16 |
| MX2010007551A (es) | 2010-11-30 |
| BRPI0906492A2 (pt) | 2015-12-01 |
| JP2011509094A (ja) | 2011-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2242769T3 (pl) | Przeciwciała przeciw domenie ec1 kadheryny 11 do leczenia zapalnych zaburzeń stawów | |
| IL257418A (en) | Methods for treating addiction | |
| HK1155374A1 (zh) | 用於治療炎性疾病和纖維變性疾病的化合物和方法 | |
| HK1212883A1 (zh) | 治療眼部疾病的方法 | |
| IL241791A0 (en) | Historical use of 3,1-diphenylprop-2-en-1-one for the treatment of liver disorders | |
| EP2331088A4 (en) | COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC ILLNESSES | |
| ZA201101823B (en) | Treating inflammatory conditions | |
| EP2309858A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
| ZA200807015B (en) | Dihydrothienopyrimidine for treating inflammatory disorders | |
| EP2170309A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF DISEASES | |
| EP2083857A4 (en) | METHOD FOR TREATING INTERFERENCE IN CONNECTION WITH MICA | |
| EP2282826A4 (en) | PROCESS FOR TREATMENT OF ODOR | |
| GB2467710B (en) | Methods for treating social disorders | |
| WO2011044264A9 (en) | Pyrrolopyrazoles for treating cns disorders | |
| ZA201203002B (en) | Compositions and methods for treating inflammatory disorders | |
| EP2331097A4 (en) | METHOD FOR TREATING CNS DISEASES | |
| EP2321379A4 (en) | METHOD FOR IMPROVING THE TRANSFER PROPERTIES OF BITUMEN | |
| EP2318436A4 (en) | ANTIBODIES OF DIFFERENT DOMAINS | |
| EP2219650A4 (en) | COMPOSITIONS AND METHODS FOR TREATING FIBROPROLIFERATIVE DISORDERS | |
| HU3578U (en) | Improved aid for facilitate the moving of cables in culverts | |
| IL207906A0 (en) | Treatment for ocular-related disorders | |
| AU2009223851A8 (en) | Methods of treating hyperacidic disorders | |
| GB0812805D0 (en) | Shower rail | |
| GB0819446D0 (en) | Treatment of inflammatory disorders | |
| IL210933A0 (en) | Compositions and methods for treating inflammatory disorders |